Ureaplasma in pregnancy. Is there any risk for preterm labor?
pdf

Keywords

Ureaplasma
preterm birth
pregnancy outcomes
inflammation
NAAT
fetal membranes

How to Cite

CAPROS, H. (2025) “Ureaplasma in pregnancy. Is there any risk for preterm labor? ”, One Health & Risk Management , 6(1), pp. 4-15. doi: 10.38045/ohrm.2025.1.01.

Abstract

Introduction. Ureaplasma species, particularly Ureaplasma urealyticum and Ureaplasma parvum, inhabit the lower genital tract of sexually active women and have been linked to adverse reproductive outcomes. This review highlights their role in preterm delivery, along with detection challenges and pathogenic mechanisms. 

Material and methods. This review compiles data from 25 studies, encompassing a total of approximately 15,700 patients. These studies include retrospective and prospective cohorts, cross-sectional designs, and case-control studies. Key parameters evaluated included impact of Ureaplasma species on pregnancy outcomes, such as preterm labor and chorioamnionitis. 

Results. The studies reviewed (2000–2024) included 10 retrospective, 8 prospective, 4 cross-sectional, and 3 case-control designs. Ureaplasma parvum was found in 40.5% of healthy women and Ureaplasma urealyticum in 20.3%. Intra-amniotic infection increased preterm delivery risk (OR: 2.76–3.0), with preterm birth rates ranging from 26% to 58.6%. Ureaplasma induces pro-inflammatory cytokines, activates neutrophils and TLR-9, and increases prostaglandin and matrix metalloproteinase activity, weakening fetal membranes and triggering preterm labor. 

Conclusions. Ureaplasma spp. significantly contribute to preterm delivery, primarily through inflammatory processes and membrane damage. Further research with prospective randomized studies is recommended.



https://doi.org/10.38045/ohrm.2025.1.01
pdf

|Views: 412| |pdf Downloads: 202|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Hristiana CAPROS

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370